Clinical Trial

Extended Perioperative Administration of Fibrinolysis Inhibitors After Cardiac Surgery

Study acronym: PRIORITY
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
PRIORITY is a pragmatic, multi-center, cluster crossover trial that aims to evaluate whether implementing a policy of routine extended (intraoperative and 4 hour after transfer to ICU) use of fibrinolysis inhibitors leads to a decrease in post-operative blood transfusion compared to a policy that only involves intraoperative use.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-08; most recent amendment 2025-01-22.
Status change: Not Yet Recruiting → Recruiting 2024-09-20
Trial Details
NCT Number NCT06493227
Lead Sponsor Saint Petersburg State University, Russia
Conditions Thoracic Surgery, Heart Diseases, Fibrinolysis Shutdown
Enrollment 1,373 participants
Start Date 2024-08-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2026-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-27